Two Sigma Investments’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Other funds holding IPXL
MC
FI
FCM
Two Sigma Investments's IPXL Position: Q3 2017 in Review
Two Sigma Investments sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 254,905 shares — an estimated $4.1M sold.
Two Sigma Investments first reported a position in IPXL in Q3 2013 and held it in 14 quarters. The position peaked at $14.1M in Q4 2016. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.
- Two Sigma Investments reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
- Two Sigma Investments sold 254,905 Impax Laboratories, Inc. shares in Q3 2017, an estimated $4.1M.
- Two Sigma Investments first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 14 quarters.
- Two Sigma Investments's Impax Laboratories, Inc. position peaked at $14.1M in Q4 2016.
- 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.
Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.